Citations (146)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Jorge A. Soto, Ricardo A. Loaiza, Sebastián Echeverría, Robinson A. Ramírez & Alexis M. Kalergis. (2023) Current and emerging pharmacological treatments for respiratory syncytial virus infection in high-risk infants. Expert Opinion on Pharmacotherapy 24:10, pages 1143-1158.
Read now
Read now
Pasquale Pagliano, Giuliana Scarpati, Carmine Sellitto, Valeria Conti, Anna Maria Spera, Tiziana Ascione, Ornella Piazza & Amelia Filippelli. (2021) Experimental Pharmacotherapy for COVID-19: The Latest Advances. Journal of Experimental Pharmacology 13, pages 1-13.
Read now
Read now
Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay & Mohamed Gomaa Kamel. (2020) Possible therapeutic agents for COVID-19: a comprehensive review. Expert Review of Anti-infective Therapy 18:10, pages 1005-1020.
Read now
Read now
Kathleen A. Cashman, Eric R. Wilkinson, Carl I. Shaia, Paul R. Facemire, Todd M. Bell, Jeremy J. Bearss, Joshua D. Shamblin, Suzanne E. Wollen, Kate E. Broderick, Niranjan Y. Sardesai & Connie S. Schmaljohn. (2017) A DNA vaccine delivered by dermal electroporation fully protects cynomolgus macaques against Lassa fever. Human Vaccines & Immunotherapeutics 13:12, pages 2902-2911.
Read now
Read now
Furong Wang, Hui Ai & Chaoliang Lei. (2013) In vitro anti-influenza activity of a protein-enriched fraction from larvae of the housefly (Musca domestica). Pharmaceutical Biology 51:3, pages 405-410.
Read now
Read now
Yanchen Zhou & Graham Simmons. (2012) Development of novel entry inhibitors targeting emerging viruses. Expert Review of Anti-infective Therapy 10:10, pages 1129-1138.
Read now
Read now
Sheli R Radoshitzky, Jens H Kuhn, Fabian de Kok-Mercado, Peter B Jahrling & Sina Bavari. (2012) Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses. Expert Opinion on Drug Discovery 7:7, pages 613-632.
Read now
Read now
Darci R Smith, Monica Ogg, Aura Garrison, Abdul Yunus, Anna Honko, Josh Johnson, Gene Olinger, Lisa E Hensley & Michael S Kinch. (2010) Development of FGI-106 as a broad-spectrum therapeutic with activity against members of the family Bunyaviridae. Virus Adaptation and Treatment 2, pages 9-20.
Read now
Read now
Véronique Loustaud-Ratti, Annick Rousseau, Pierre Marquet, François Denis & Sophie Alain. (2009) Ribavirin in chronic hepatitis C: past and future. Expert Review of Anti-infective Therapy 7:3, pages 249-253.
Read now
Read now
Katharine N Bossart & Christopher C Broder. (2006) Developments towards effective treatments for Nipah and Hendra virus infection. Expert Review of Anti-infective Therapy 4:1, pages 43-55.
Read now
Read now
Noel JC Snell. (2004) Novel and re-emerging respiratory infections. Expert Review of Anti-infective Therapy 2:3, pages 405-412.
Read now
Read now
Articles from other publishers (135)
Zhen-Xi Niu, Peng Nie, Piet Herdewijn & Ya-Tao Wang. (2023) Synthetic approaches and application of clinically approved small-molecule drugs to treat hepatitis. European Journal of Medicinal Chemistry 262, pages 115919.
Crossref
Crossref
Jihui Kuang, Mingzhu Liu, Qing Yu, Yuan Cheng, Jing Huang, Shuyu Han, Jingu Shi, Lin Huang & Pengfei Li. (2023) Antiviral Effect and Mechanism of Edaravone against Grouper Iridovirus Infection. Viruses 15:11, pages 2237.
Crossref
Crossref
Wendong Jia, Yusheng Ouyang, Shanyu Zhang, Xiaoyu Du, Panke Zhang & Shuo Huang. (2023) Nanopore Signatures of Nucleoside Drugs. Nano Letters 23:20, pages 9437-9444.
Crossref
Crossref
Ahmed Faried Abdel Hakiem, John M. Boushra, Deena A. M. Noureldeen, Adel S. Lashien & Tamer Z. Attia. (2023) Nano-fluorescent quantum dots as substrates for determination of ribavirin in pharmaceuticals and human plasma as well as monitoring of its kinetic interaction with salmon sperm DNA. Journal of Analytical Science and Technology 14:1.
Crossref
Crossref
Shilpa Chatterjee, Arindam Maity & Debanjan Sen. 2023. Current Trends in Computational Modeling for Drug Discovery. Current Trends in Computational Modeling for Drug Discovery
195
211
.
Kacper Pizon, Savita Hampal, Kamila Orzechowska & Shahid Nazir Muhammad. 2023. Biomedical Visualisation. Biomedical Visualisation
41
57
.
Olga S. Smirnova, Maria Ya. Berzina, Ilya V. Fateev, Barbara Z. Eletskaya, Maria A. Kostromina, Alexey L. Kaushin, Alexander S. Paramonov, Alexander N. Prutkov, Andrey V. Matveev, Lyubov E. Grebenkina, Mikhail V. Chudinov, Valeria L. Andronova, Georgiy A. Galegov, Petr G. Deryabin, Anatoly I. Miroshnikov, Roman S. Esipov & Irina D. Konstantinova. (2022) Chemo-enzymatic synthesis of 5-substituted ribavirin analogs: Unexpected cooperative effect in the interaction of 5-alkyloxymethyl 1,2,4-triazol-3-carboxamides with E. coli purine nucleoside phosphorylase active site. Sustainable Chemistry and Pharmacy 30, pages 100881.
Crossref
Crossref
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen & Yiming Mu. (2022) A systematic review and meta-analysis of endocrine-related adverse events associated with interferon. Frontiers in Endocrinology 13.
Crossref
Crossref
Ralph A. Tripp & David E. Martin. (2022) Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Viruses 14:3, pages 612.
Crossref
Crossref
I. García-Silva, G. Palestino & O. Gonzalez-Ortega. 2022. Biomedical Innovations to Combat COVID-19. Biomedical Innovations to Combat COVID-19
307
337
.
Bing Gao, Dongdong Zhao, Lingmu Li, Zhigang Cheng & Ye Guo. (2021)
Antiviral Peptides with
in vivo
Activity: Development and Modes of Action
. ChemPlusChem 86:12, pages 1547-1558.
Crossref
Crossref
Taimoor Khan, Abbas Khan & Dong-Qing Wei. (2021) MMV-db: vaccinomics and RNA-based therapeutics database for infectious hemorrhagic fever-causing mammarenaviruses. Database 2021.
Crossref
Crossref
Q. Ren, P. -Y. Huang, Y. Liu, W. -K. Liao, Z. -X. Zhou & C. -S. Zhao. (2021) SYNTHESIS, CRYSTAL STRUCTURE, AND DFT STUDY OF 4-(2-CHLOROBENZYL)-1-(5-NITRO-2-(PYRROLIDIN-1-YL)PHENYL)- [1,2,4]TRIAZOLO[4,3-a]QUINAZOLIN-5(4H)-ONE. Journal of Structural Chemistry 62:9, pages 1472-1482.
Crossref
Crossref
Oloche Owoicho, Kesego Tapela, Alexandra Lindsey Djomkam Zune, Nora Nganyewo Nghochuzie, Abiola Isawumi & Lydia Mosi. (2021) Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?. Future Microbiology 16:12, pages 919-925.
Crossref
Crossref
Scott J. Barraza, Janice A. Sindac, Craig J. Dobry, Philip C. Delekta, Pil H. Lee, David J. Miller & Scott D. Larsen. (2021) Synthesis and biological activity of conformationally restricted indole-based inhibitors of neurotropic alphavirus replication: Generation of a three-dimensional pharmacophore. Bioorganic & Medicinal Chemistry Letters 46, pages 128171.
Crossref
Crossref
Serena Massari, Jenny Desantis, Maria Giulia Nizi, Violetta Cecchetti & Oriana Tabarrini. (2020) Inhibition of Influenza Virus Polymerase by Interfering with Its Protein–Protein Interactions. ACS Infectious Diseases 7:6, pages 1332-1350.
Crossref
Crossref
George D Liatsos. (2021) Controversies’ clarification regarding ribavirin efficacy in measles and coronaviruses: Comprehensive therapeutic approach strictly tailored to COVID-19 disease stages. World Journal of Clinical Cases 9:19, pages 5135-5178.
Crossref
Crossref
Luana Bauso, Chiara Imbesi, Gasparo Irene, Gabriella Calì & Alessandra Bitto. (2021) New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection. Pharmaceuticals 14:6, pages 503.
Crossref
Crossref
Therese MathewBadmanaban. RAby PaulBharat Mishra. (2021) A Review on Deadly Nipah Virus - Prevalence and its Management. Research Journal of Pharmacy and Technology, pages 2302-2307.
Crossref
Crossref
Frederick Hansen, Michael A. Jarvis, Heinz Feldmann & Kyle Rosenke. (2021) Lassa Virus Treatment Options. Microorganisms 9:4, pages 772.
Crossref
Crossref
Luís Jesuíno de Oliveira Andrade, Ajax Mercês Attas, Argemiro D’Oliveira Junior & Raymundo Paraná. 2021. Hepatite C e tireoide. Hepatite C e tireoide
137
154
.
Luís Jesuíno de Oliveira Andrade, Larissa Santos França, Luciana Santos França, Ana Líbia Oliveira França de Sousa & Alcina Maria Vinhaes Bittencourt. 2021. Hepatite C e tireoide. Hepatite C e tireoide
123
136
.
Ippei Yoshida, Kaho Arikawa, Yusuke Honma, Shoko Inatani, Mitsukane Yoshinaga & Hiroyuki Sugiyama. (2020) Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants. Antimicrobial Agents and Chemotherapy 65:1.
Crossref
Crossref
Cherukupalle Bhuvaneswar, Aluru Rammohan, Baki Vijaya Bhaskar, Pappithi Ramesh Babu, Gujjar Naveen, Duvvuru Gunasekar, Subbiah Madhuri, Pallu Reddanna & Wudayagiri Rajendra. (2020)
Sophora interrupta
Bedd. root-derived flavonoids as prominent antiviral agents against Newcastle disease virus
. RSC Advances 10:55, pages 33534-33543.
Crossref
Crossref
Xiaoqian Deng, Shijun Tian, Zhengsen Yu, Lili Wang, Ruiying Liang, Yanbai Li, Rong Xiang, Shibo Jiang, Tianlei Ying & Fei Yu. (2020) Development of small-molecule inhibitors against hantaviruses. Microbes and Infection 22:6-7, pages 272-277.
Crossref
Crossref
E. Piantanida, S. Ippolito, D. Gallo, E. Masiello, P. Premoli, C. Cusini, S. Rosetti, J. Sabatino, S. Segato, F. Trimarchi, L. Bartalena & M. L. Tanda. (2020) The interplay between thyroid and liver: implications for clinical practice. Journal of Endocrinological Investigation 43:7, pages 885-899.
Crossref
Crossref
Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik & Matthew D. Hall. (2020) Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19. ACS Central Science 6:5, pages 672-683.
Crossref
Crossref
Richard K Plemper. (2020) Measles Resurgence and Drug Development. Current Opinion in Virology 41, pages 8-17.
Crossref
Crossref
Mutsuyo Takayama-Ito & Masayuki Saijo. (2020) Antiviral Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus Infection. Frontiers in Microbiology 11.
Crossref
Crossref
Amrit Krishna Mitra. (2020) Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19. AIMS Molecular Science 7:3, pages 269-280.
Crossref
Crossref
Esteban Domingo. 2020. Virus as Populations. Virus as Populations
301
339
.
Juan-Carlos Saiz. (2019) Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go. Pharmaceuticals 12:3, pages 127.
Crossref
Crossref
Belén Borrego, Ana I. de Ávila, Esteban Domingo & Alejandro Brun. (2019) Lethal Mutagenesis of Rift Valley Fever Virus Induced by Favipiravir. Antimicrobial Agents and Chemotherapy 63:8.
Crossref
Crossref
Angelica Cifuentes Kottkamp, Elfie De Jesus, Rebecca Grande, Julia A. Brown, Adam R. Jacobs, Jean K. Lim & Kenneth A. Stapleford. (2019) Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides. Journal of Virology 93:11.
Crossref
Crossref
Natalie E. Netzler, Daniel Enosi Tuipulotu & Peter A. White. (2018) Norovirus antivirals: Where are we now?. Medicinal Research Reviews 39:3, pages 860-886.
Crossref
Crossref
Sandra Piras, Giuseppina Sanna, Antonio Carta, Paola Corona, Roberta Ibba, Roberta Loddo, Silvia Madeddu, Paola Caria, Suzana Aulic, Erik Laurini, Maurizio Fermeglia & Sabrina Pricl. (2019) Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors. Frontiers in Chemistry 7.
Crossref
Crossref
Susan Oliver, Lily Zhao, Adam J. Gormley, Robert Chapman & Cyrille Boyer. (2018) Living in the Fast Lane—High Throughput Controlled/Living Radical Polymerization. Macromolecules 52:1, pages 3-23.
Crossref
Crossref
Hui-Jun Dong, Zhao-Hua Wang, Wen Meng, Cui-Cui Li, Yan-Xin Hu, Lei Zhou & Xiao-Jia Wang. (2018) The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo. Viruses 10:11, pages 601.
Crossref
Crossref
Maria Rosaria Bassi, Raquel Navarro Sempere, Prashansa Meyn, Charlotta Polacek & Armando Arias. (2018) Extinction of Zika Virus and Usutu Virus by Lethal Mutagenesis Reveals Different Patterns of Sensitivity to Three Mutagenic Drugs. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Crossref
Juan-Carlos Saiz, Nereida Oya, Ana-Belén Blázquez, Estela Escribano-Romero & Miguel Martín-Acebes. (2018) Host-Directed Antivirals: A Realistic Alternative to Fight Zika Virus. Viruses 10:9, pages 453.
Crossref
Crossref
Kaja Zuwala, Camilla F. Riber, Kaja Borup Løvschall, Anna H.F. Andersen, Lise Sørensen, Paulina Gajda, Martin Tolstrup & Alexander N. Zelikin. (2018) Macromolecular prodrugs of ribavirin: Polymer backbone defines blood safety, drug release, and efficacy of anti-inflammatory effects. Journal of Controlled Release 275, pages 53-66.
Crossref
Crossref
Ramesh N. Patel. (2018) Biocatalysis for synthesis of pharmaceuticals. Bioorganic & Medicinal Chemistry 26:7, pages 1252-1274.
Crossref
Crossref
Paul C Jordan, Sarah K Stevens & Jerome Deval. (2018) Nucleosides for the treatment of respiratory RNA virus infections. Antiviral Chemistry and Chemotherapy 26, pages 204020661876448.
Crossref
Crossref
Robert S. Adcock, Yong-Kyu Chu, Jennifer E. Golden & Dong-Hoon Chung. (2017) Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Antiviral Research 138, pages 47-56.
Crossref
Crossref
Camilla Frich Riber, Tracey M. Hinton, Paulina Gajda, Kaja Zuwala, Martin Tolstrup, Cameron Stewart & Alexander N. Zelikin. (2016) Macromolecular Prodrugs of Ribavirin: Structure–Function Correlation as Inhibitors of Influenza Infectivity. Molecular Pharmaceutics 14:1, pages 234-241.
Crossref
Crossref
George V. Guibas & Nikolaos G. Papadopoulos. 2017. Viral Infections in Children, Volume II. Viral Infections in Children, Volume II
1
25
.
Yin Mo & Dale Fisher. (2016) A review of treatment modalities for Middle East Respiratory Syndrome. Journal of Antimicrobial Chemotherapy 71:12, pages 3340-3350.
Crossref
Crossref
Bonto Faburay & Juergen A. Richt. (2016) Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells. Frontiers in Microbiology 7.
Crossref
Crossref
Daniel Todt, Stephanie Walter, Richard Brown & Eike Steinmann. (2016) Mutagenic Effects of Ribavirin on Hepatitis E Virus—Viral Extinction versus Selection of Fitness-Enhancing Mutations. Viruses 8:10, pages 283.
Crossref
Crossref
Luis Martínez-Sobrido & Juan de la Torre. (2016) Reporter-Expressing, Replicating-Competent Recombinant Arenaviruses. Viruses 8:7, pages 197.
Crossref
Crossref
Max Crispin, Antra Zeltina, Nicole Zitzmann & Thomas A Bowden. (2016) Native functionality and therapeutic targeting of arenaviral glycoproteins. Current Opinion in Virology 18, pages 70-75.
Crossref
Crossref
Md. Koushikul Islam, Maria Baudin, Jonas Eriksson, Christopher Öberg, Matthias Habjan, Friedemann Weber, Anna K. Överby, Clas Ahlm & Magnus Evander. (2016) High-Throughput Screening Using a Whole-Cell Virus Replication Reporter Gene Assay to Identify Inhibitory Compounds against Rift Valley Fever Virus Infection. SLAS Discovery 21:4, pages 354-362.
Crossref
Crossref
Zygmunt F. Dembek & Theodore J. Cieslak. 2016. Koenig and Schultz's Disaster Medicine. Koenig and Schultz's Disaster Medicine
522
543
.
Véronique Loustaud-Ratti. (2016) Ribavirin: Past, present and future. World Journal of Hepatology 8:2, pages 123.
Crossref
Crossref
Esteban Domingo. 2016. Virus as Populations. Virus as Populations
299
338
.
Christopher C. Broder & Kum Thong Wong. 2016. Neurotropic Viral Infections. Neurotropic Viral Infections
45
83
.
Luis Martínez-Sobrido, Benson Yee Hin Cheng & Juan Carlos de la Torre. 2016. Vaccine Design. Vaccine Design
313
351
.
Franz-Ferdinand RochGeorg HinterkörnerJohn MenkeGuo-Qing TangStephen CusackBarbara ButzendoblerHelmut BuschmannKausiki DattaAndrea Wolkerstorfer. (2015) An RNA Hybridization Assay for Screening Influenza A Virus Polymerase Inhibitors Using the Entire Ribonucleoprotein Complex. ASSAY and Drug Development Technologies 13:8, pages 488-506.
Crossref
Crossref
P. Guillaume Poliquin, Michael Drebot, Allen Grolla, Shane E. Jones, Bryce Larke & James E. Strong. (2015) Therapeutic Approaches for New World Hantaviruses. Current Treatment Options in Infectious Diseases 7:3, pages 230-239.
Crossref
Crossref
Lonneke Linden, Katja Wolthers & Frank van Kuppeveld. (2015) Replication and Inhibitors of Enteroviruses and Parechoviruses. Viruses 7:8, pages 4529-4562.
Crossref
Crossref
Matthew L. BoisenJohn S. SchieffelinAugustine GobaDarin OottamasathienAbigail B. JonesJeffrey G. ShafferKathryn M. HastieJessica N. HartnettMambu MomohMohammed FullahMichael GabikiSidiki SafaMichelle ZandonattiMarnie FuscoZach BornholdtDafna AbelsonStephen K. GireKristian G. AndersenRidhi TariyalMathew StremlauRobert W. CrossJoan B. GeisbertKelly R. PittsThomas W. GeisbertPeter KulakoskiRussell B. WilsonLee HendersonPardis C. SabetiDonald S. GrantRobert F. GarryErica O. SaphireLuis M. BrancoSheik Humarr Khan. (2015) Multiple Circulating Infections Can Mimic the Early Stages of Viral Hemorrhagic Fevers and Possible Human Exposure to Filoviruses in Sierra Leone Prior to the 2014 Outbreak. Viral Immunology 28:1, pages 19-31.
Crossref
Crossref
Sarah Allegra, Jessica Cusato, Amedeo De Nicolò, Lucio Boglione, Alberto Gatto, Giuseppe Cariti, Giovanni Di Perri & Antonio D’Avolio. (2015) Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients. Biomedicine & Pharmacotherapy 69, pages 47-55.
Crossref
Crossref
Anton A. A. Smith, Kaja Zuwala, Mille B. L. Kryger, Benjamin M. Wohl, Carlos Guerrero-Sanchez, Martin Tolstrup, Almar Postma & Alexander N. Zelikin. (2015) Macromolecular prodrugs of ribavirin: towards a treatment for co-infection with HIV and HCV. Chemical Science 6:1, pages 264-269.
Crossref
Crossref
Emmie de Wit & Vincent J. Munster. 2015. Global Virology I - Identifying and Investigating Viral Diseases. Global Virology I - Identifying and Investigating Viral Diseases
125
146
.
Pau Ruiz-Sanchis, Benjamin M. Wohl, Anton A. A. Smith, Kaja Zuwala, Jesper Melchjorsen, Martin Tolstrup & Alexander N. Zelikin. (2015) Highly Active Macromolecular Prodrugs Inhibit Expression of the Hepatitis C Virus Genome in the Host Cells. Advanced Healthcare Materials 4:1, pages 65-68.
Crossref
Crossref
Qian Gao, Zhen Wang, Zhenlong Liu, Xiaoyu Li, Yongxin Zhang, Zhizhen Zhang & Shan Cen. (2014) A cell-based high-throughput approach to identify inhibitors of influenza A virus. Acta Pharmaceutica Sinica B 4:4, pages 301-306.
Crossref
Crossref
Amy L. Caroline, Diana S. Powell, Laura M. Bethel, Tim D. Oury, Douglas S. Reed & Amy L. Hartman. (2014) Broad Spectrum Antiviral Activity of Favipiravir (T-705): Protection from Highly Lethal Inhalational Rift Valley Fever. PLoS Neglected Tropical Diseases 8:4, pages e2790.
Crossref
Crossref
Dionna Scharton, Kevin W. Bailey, Zachary Vest, Jonna B. Westover, Yohichi Kumaki, Arnaud Van Wettere, Yousuke Furuta & Brian B. Gowen. (2014) Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment. Antiviral Research 104, pages 84-92.
Crossref
Crossref
Jeffrey G. Shaffer, Donald S. Grant, John S. Schieffelin, Matt L. Boisen, Augustine Goba, Jessica N. Hartnett, Danielle C. Levy, Rachael E. Yenni, Lina M. Moses, Mohammed Fullah, Mambo Momoh, Mbalu Fonnie, Richard Fonnie, Lansana Kanneh, Veronica J. Koroma, Kandeh Kargbo, Darin Ottomassathien, Ivana J. Muncy, Abigail B. Jones, Megan M. Illick, Peter C. Kulakosky, Allyson M. Haislip, Christopher M. Bishop, Deborah H. Elliot, Bethany L. Brown, Hu Zhu, Kathryn M. Hastie, Kristian G. Andersen, Stephen K. Gire, Shervin Tabrizi, Ridhi Tariyal, Mathew Stremlau, Alex Matschiner, Darryl B. Sampey, Jennifer S. Spence, Robert W. Cross, Joan B. Geisbert, Onikepe A. Folarin, Christian T. Happi, Kelly R. Pitts, F. Jon Geske, Thomas W. Geisbert, Erica Ollmann Saphire, James E. Robinson, Russell B. Wilson, Pardis C. Sabeti, Lee A. Henderson, S. Humarr Khan, Daniel G. Bausch, Luis M. Branco & Robert F. Garry. (2014) Lassa Fever in Post-Conflict Sierra Leone. PLoS Neglected Tropical Diseases 8:3, pages e2748.
Crossref
Crossref
Anton A. A. Smith, Mille B. L. Kryger, Benjamin M. Wohl, Pau Ruiz-Sanchis, Kaja Zuwala, Martin Tolstrup & Alexander N. Zelikin. (2014) Macromolecular (pro)drugs in antiviral research. Polym. Chem. 5:22, pages 6407-6425.
Crossref
Crossref
Monica Ogg, Colleen Jonsson, Jeremy Camp & Jay Hooper. (2013) Ribavirin Protects Syrian Hamsters against Lethal Hantavirus Pulmonary Syndrome — After Intranasal Exposure to Andes Virus. Viruses 5:11, pages 2704-2720.
Crossref
Crossref
Wei Liu, Qing-Bin Lu, Ning Cui, Hao Li, Li-Yuan Wang, Kun Liu, Zhen-Dong Yang, Bing-Jun Wang, Hong-Yu Wang, Yao-Yun Zhang, Lu Zhuang, Chun-Yan Hu, Chun Yuan, Xue-Juan Fan, Zhen Wang, Lan Zhang, Xiao-Ai Zhang, David H. Walker & Wu-Chun Cao. (2013) Case-Fatality Ratio and Effectiveness of Ribavirin Therapy Among Hospitalized Patients in China Who Had Severe Fever With Thrombocytopenia Syndrome. Clinical Infectious Diseases 57:9, pages 1292-1299.
Crossref
Crossref
Christopher C. Broder, Kai Xu, Dimitar B. Nikolov, Zhongyu Zhu, Dimiter S. Dimitrov, Deborah Middleton, Jackie Pallister, Thomas W. Geisbert, Katharine N. Bossart & Lin-Fa Wang. (2013) A treatment for and vaccine against the deadly Hendra and Nipah viruses. Antiviral Research 100:1, pages 8-13.
Crossref
Crossref
Ana M. Ortega-Prieto, Julie Sheldon, Ana Grande-Pérez, Héctor Tejero, Josep Gregori, Josep Quer, Juan I. Esteban, Esteban Domingo & Celia Perales. (2013) Extinction of Hepatitis C Virus by Ribavirin in Hepatoma Cells Involves Lethal Mutagenesis. PLoS ONE 8:8, pages e71039.
Crossref
Crossref
Mille B. L. Kryger, Benjamin M. Wohl, Anton A. A. Smith & Alexander N. Zelikin. (2013) Macromolecular prodrugs of ribavirin combat side effects and toxicity with no loss of activity of the drug. Chemical Communications 49:26, pages 2643.
Crossref
Crossref
Regina Elizondo-Gonzalez, L Elizabeth Cruz-Suarez, Denis Ricque-Marie, Edgar Mendoza-Gamboa, Cristina Rodriguez-Padilla & Laura M Trejo-Avila. (2012) In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus. Virology Journal 9:1.
Crossref
Crossref
Zehui Yan, Ke Fan, Yi Fan, Xiaohong Wang, Qing Mao, Guohong Deng & Yuming Wang. (2012) Thyroid Dysfunction in Chinese Patients with Chronic Hepatitis C Treated with Interferon Alpha: Incidence, Long-Term Outcome and Predictive Factors. Hepatitis Monthly 12:9.
Crossref
Crossref
Kalyan Das. (2012) Antivirals Targeting Influenza A Virus. Journal of Medicinal Chemistry 55:14, pages 6263-6277.
Crossref
Crossref
Nahid ShahabadiZeinab Mirzaei kalarAsad Vaisi-Raygani. (2012) DNA Interaction Studies of an Antiviral Drug, Ribavirin, Using Different Instrumental Methods. DNA and Cell Biology 31:5, pages 876-882.
Crossref
Crossref
Guofeng Zhang, Feng Zhou, Bin Gu, Chuanling Ding, Dongju Feng, Fangyi Xie, Jinfeng Wang, Chun Zhang, Qingxian Cao, Yinlai Deng, Weixing Hu & Kun Yao. (2012) In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Archives of Virology 157:4, pages 669-679.
Crossref
Crossref
L. A. Alexandrova. (2011) 4′-C-nucleoside derivatives: Synthesis and antiviral properties. Russian Journal of Bioorganic Chemistry 37:6, pages 651-671.
Crossref
Crossref
Celia Perales, Verónica Martín & Esteban Domingo. (2011) Lethal mutagenesis of viruses. Current Opinion in Virology 1:5, pages 419-422.
Crossref
Crossref
Vasiliadis Themistoklis, Anagnostis Panagiotis, Nalmpantidis Georgios, Soufleris Konstantinos, Patsiaoura Kaliopi, Grammatikos Nikolaos, Orfanou-Koumerkeridou Eleni, Kargiotis Konstantinos, Slavakis Aristidis, Deliyiannidis Aristidis & Eugenidis Nikolaos. (2011) Thyroid Dysfunction and Long-term Outcome during and after Interferon-alpha Therapy in Patients with Chronic Hepatitis C. Annals of the Academy of Medicine, Singapore 40:9, pages 394-400.
Crossref
Crossref
Masfique Mehedi, Allison Groseth, Heinz Feldmann & Hideki Ebihara. (2011) Clinical aspects of Marburg hemorrhagic fever. Future Virology 6:9, pages 1091-1106.
Crossref
Crossref
David Safronetz, Elaine Haddock, Friederike Feldmann, Hideki Ebihara & Heinz Feldmann. (2011) In Vitro and In Vivo Activity of Ribavirin against Andes Virus Infection. PLoS ONE 6:8, pages e23560.
Crossref
Crossref
Héctor Moreno, Isabel Gallego, Noemí Sevilla, Juan Carlos de la Torre, Esteban Domingo & Verónica Martín. (2011) Ribavirin Can Be Mutagenic for Arenaviruses. Journal of Virology 85:14, pages 7246-7255.
Crossref
Crossref
Luis Jesuino de Oliveira Andrade, Ajax Mercês Atta, Maria Luiza Brito de Sousa Atta, Célia Neder Kalil Mangabeira & Raymundo Paraná. (2011) Thyroid disorders in patients with chronic hepatitis C using interferon-alpha and ribavirin therapy. The Brazilian Journal of Infectious Diseases 15:4, pages 377-381.
Crossref
Crossref
Janice M. Rusnak. (2011) Experience with Ribavirin for Treatment and Postexposure Prophylaxis of Hemorrhagic Fever Viruses: Crimean Congo Hemorrhagic Fever, Lassa Fever, and Hantaviruses. Applied Biosafety 16:2, pages 67-87.
Crossref
Crossref
Michelle Mendenhall, Andrew Russell, Terry Juelich, Emily L. Messina, Donald F. Smee, Alexander N. Freiberg, Michael R. Holbrook, Yousuke Furuta, Juan-Carlos de la Torre, Jack H. Nunberg & Brian B. Gowen. (2011) T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture. Antimicrobial Agents and Chemotherapy 55:2, pages 782-787.
Crossref
Crossref
Hector C. Aguilar & Benhur Lee. (2011) Emerging paramyxoviruses: molecular mechanisms and antiviral strategies. Expert Reviews in Molecular Medicine 13.
Crossref
Crossref
Brian B. Gowen, Min-Hui Wong, Deanna Larson, Wei Ye, Kie-Hoon Jung, Eric J. Sefing, Ramona Skirpstunas, Donald F. Smee, John D. Morrey & Stewart W. Schneller. (2010) Development of a New Tacaribe Arenavirus Infection Model and Its Use to Explore Antiviral Activity of a Novel Aristeromycin Analog. PLoS ONE 5:9, pages e12760.
Crossref
Crossref
Rubén Agudo, Cristina Ferrer-Orta, Armando Arias, Ignacio de la Higuera, Celia Perales, Rosa Pérez-Luque, Nuria Verdaguer & Esteban Domingo. (2010) A Multi-Step Process of Viral Adaptation to a Mutagenic Nucleoside Analogue by Modulation of Transition Types Leads to Extinction-Escape. PLoS Pathogens 6:8, pages e1001072.
Crossref
Crossref
M. A. Ivanov, G. S. Ludva, A. V. Mukovnya, S. N. Kochetkov, V. L. Tunitskaya & L. A. Alexandrova. (2010) Synthesis and biological properties of pyrimidine 4′-fluoronucleosides and 4′-fluorouridine 5′-O-triphosphate. Russian Journal of Bioorganic Chemistry 36:4, pages 488-496.
Crossref
Crossref
Marco Derudas, Andrea Brancale, Lieve Naesens, Johan Neyts, Jan Balzarini & Christopher McGuigan. (2010) Application of the phosphoramidate ProTide approach to the antiviral drug ribavirin. Bioorganic & Medicinal Chemistry 18:7, pages 2748-2755.
Crossref
Crossref
Shayne Cox GadPaul D. Olivo. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Noel J. C. Snell. (2012) Pandemic Influenza — Prevention and Treatment. Pharmaceutical Medicine 24:1, pages 1-6.
Crossref
Crossref
Celia Perales, Rubén Agudo, Hector Tejero, Susanna C. Manrubia & Esteban Domingo. (2009) Potential Benefits of Sequential Inhibitor-Mutagen Treatments of RNA Virus Infections. PLoS Pathogens 5:11, pages e1000658.
Crossref
Crossref
Robert G. Darling, Jon B. Woods & Theodore J. Cieslak. 2011. Koenig and Schultz's Disaster Medicine. Koenig and Schultz's Disaster Medicine
454
476
.
Mika Okamoto, Masashi Sakai, Yukinori Goto, Mohammed TA Salim, Chiaki Baba, Kaku Goto, Koichi Watashi, Kunitada Shimotohno & Masanori Baba. (2009) Anti-Bovine Viral Diarrhoea Virus and Hepatitis C Virus Activity of the Cyclooxygenase Inhibitor SC-560. Antiviral Chemistry and Chemotherapy 20:1, pages 47-54.
Crossref
Crossref
Celia Perales, Rubén Agudo & Esteban Domingo. (2009) Counteracting Quasispecies Adaptability: Extinction of a Ribavirin-Resistant Virus Mutant by an Alternative Mutagenic Treatment. PLoS ONE 4:5, pages e5554.
Crossref
Crossref
Florence Morfin, Sophie Dupuis-Girod, Emilie Frobert, Stéphanie Mundweiler, David Carrington, Petr Sedlacek, Marc Bierings, Petr Cetkovsky, Aloys CM Kroes, Maarten JD van Tol & Danielle Thouvenot. (2009) Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone. Antiviral Therapy 14:1, pages 55-61.
Crossref
Crossref
Mitchell L. Shiffman. (2009) What future for ribavirin?. Liver International 29, pages 68-73.
Crossref
Crossref
B. Müller & Hans-Georg Kräusslich. 2009. Antiviral Strategies. Antiviral Strategies
1
24
.
Kimberly A. Bishop & Christopher C. Broder. 2008. Emerging Infections 8. Emerging Infections 8
155
187
.
M. A. Ivanov, A. V. Ivanov, I. A. Krasnitskaya, O. A. Smirnova, I. L. Karpenko, E. F. Belanov, V. S. Prasolov, V. L. Tunitskaya & L. A. Alexandrova. (2008) New furano- and pyrrolo[2,3-d]pyrimidine nucleosides and their 5′-O-triphosphates: Synthesis and biological properties. Russian Journal of Bioorganic Chemistry 34:5, pages 593-601.
Crossref
Crossref
W. Garrett Nichols, Angela J. Peck Campbell & Michael Boeckh. (2008) Respiratory Viruses Other than Influenza Virus: Impact and Therapeutic Advances. Clinical Microbiology Reviews 21:2, pages 274-290.
Crossref
Crossref
Vasu Nair & Qingning Shu. (2016) Inosine Monophosphate Dehydrogenase as a Probe in Antiviral Drug Discovery. Antiviral Chemistry and Chemotherapy 18:5, pages 245-258.
Crossref
Crossref
Brian B. Gowen, Min-Hui Wong, Kie-Hoon Jung, Andrew B. Sanders, Michelle Mendenhall, Kevin W. Bailey, Yousuke Furuta & Robert W. Sidwell. (2007) In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections. Antimicrobial Agents and Chemotherapy 51:9, pages 3168-3176.
Crossref
Crossref
Macarena Sierra, Antero Airaksinen, Claudia González-López, Rubén Agudo, Armando Arias & Esteban Domingo. (2007) Foot-and-Mouth Disease Virus Mutant with Decreased Sensitivity to Ribavirin: Implications for Error Catastrophe. Journal of Virology 81:4, pages 2012-2024.
Crossref
Crossref
Brian B Gowen, Donald F Smee, Min-Hui Wong, Anne M Pace, Kie-Hoon Jung, Kevin W Bailey, Lawrence M Blatt & Robert W Sidwell. (2016) Combinatorial Ribavirin and Interferon Alfacon-1 Therapy of Acute Arenaviral Disease in Hamsters. Antiviral Chemistry and Chemotherapy 17:4, pages 175-183.
Crossref
Crossref
Chao-Jiang Gu, Cong-Yi Zheng, Qian Zhang, Li-Li Shi, Yong Li & San-Fu Qu. (2006) An Antiviral Mechanism Investigated with Ribavirin as an RNA Virus Mutagen for Foot-and-mouth Disease Virus. BMB Reports 39:1, pages 9-15.
Crossref
Crossref
E. Domingo, V. Martín, C. Perales, A. Grande-Pérez, J. García-Arriaza & A. Arias. 2006. Quasispecies: Concept and Implications for Virology. Quasispecies: Concept and Implications for Virology
51
82
.
Charles M. Rice & Shihyun You. (2005) Treating hepatitis C: Can you teach old dogs new tricks?. Hepatology 42:6, pages 1455-1458.
Crossref
Crossref
Ana Grande-Pérez, Gema Gómez-Mariano, Pedro R. Lowenstein & Esteban Domingo. (2005) Mutagenesis-Induced, Large Fitness Variations with an Invariant Arenavirus Consensus Genomic Nucleotide Sequence. Journal of Virology 79:16, pages 10451-10459.
Crossref
Crossref
Daniel Kolakofsky, Laurent Roux, Dominique Garcin & Rob W. H. Ruigrok. (2005) Paramyxovirus mRNA editing, the ‘rule of six’ and error catastrophe: a hypothesis. Journal of General Virology 86:7, pages 1869-1877.
Crossref
Crossref
Chong-Tin Tan, K Wong & Kaw-Bing Chua. 2005. Emerging Neurological Infections. Emerging Neurological Infections
59
75
.
Pieter Leyssen, Jan Balzarini, Erik De Clercq & Johan Neyts. (2005) The Predominant Mechanism by Which Ribavirin Exerts Its Antiviral Activity In Vitro against Flaviviruses and Paramyxoviruses Is Mediated by Inhibition of IMP Dehydrogenase. Journal of Virology 79:3, pages 1943-1947.
Crossref
Crossref
Juan Carlos de la Torre. (2005) Arenavirus extinction through lethal mutagenesis. Virus Research 107:2, pages 207-214.
Crossref
Crossref
Nonia Pariente, Saleta Sierra & Antero Airaksinen. (2005) Action of mutagenic agents and antiviral inhibitors on foot-and-mouth disease virus. Virus Research 107:2, pages 183-193.
Crossref
Crossref
E. Domingo, N. Pariente, A. Airaksinen, C. González-Lopez, S. Sierra, M. Herrera, A. Grande-Pérez, P. R. Lowenstein, S. C. Manrubia, E. Lázaro & C. Escarmís. 2005. Foot-and-Mouth Disease Virus. Foot-and-Mouth Disease Virus
149
173
.
E. Domingo, C. Gonzalez-Lopez, N. Pariente, A. Airaksinen & C. Escarmís. 2005. Infectious Diseases from Nature: Mechanisms of Viral Emergence and Persistence. Infectious Diseases from Nature: Mechanisms of Viral Emergence and Persistence
59
71
.
Sheila M. L. Waugh & William F. Carman. 2005. Antibiotic Policies. Antibiotic Policies
331
349
.
Cristina Ferrer-Orta, Armando Arias, Rosa Perez-Luque, Cristina Escarmís, Esteban Domingo & Nuria Verdaguer. (2004) Structure of Foot-and-Mouth Disease Virus RNA-dependent RNA Polymerase and Its Complex with a Template-Primer RNA. Journal of Biological Chemistry 279:45, pages 47212-47221.
Crossref
Crossref
N. J. C. Snell. (2004) Ribavirin Therapy for Nipah Virus Infection. Journal of Virology 78:18, pages 10211-10211.
Crossref
Crossref
Jason D. MatthewsEdmund J. Bini. (2016) Epidemiology, Diagnosis, and Treatment of Chronic Hepatitis C. Journal of Pharmacy Practice 17:4, pages 229-238.
Crossref
Crossref
Pamela A. Wilkins & Fabio Del Piero. (2004) West Nile virus: lessons from the 21st century. Journal of Veterinary Emergency and Critical Care 14:1, pages 2-14.
Crossref
Crossref
Jean-Michel Pawlotsky, Harel Dahari, Avidan U. Neumann, Christophe Hezode, Georgios Germanidis, Isabelle Lonjon, Laurent Castera & Daniel Dhumeaux. (2004) Antiviral action of ribavirin in chronic hepatitis C. Gastroenterology 126:3, pages 703-714.
Crossref
Crossref
David Durantel, Sandra Carrouée-Durantel, Norica Branza-Nichita, Raymond A. Dwek & Nicole Zitzmann. (2004) Effects of Interferon, Ribavirin, and Iminosugar Derivatives on Cells Persistently Infected with Noncytopathic Bovine Viral Diarrhea Virus. Antimicrobial Agents and Chemotherapy 48:2, pages 497-504.
Crossref
Crossref
V. Guillaume, H. Contamin, P. Loth, M.-C. Georges-Courbot, A. Lefeuvre, P. Marianneau, K. B. Chua, S. K. Lam, R. Buckland, V. Deubel & T. F. Wild. (2004) Nipah Virus: Vaccination and Passive Protection Studies in a Hamster Model. Journal of Virology 78:2, pages 834-840.
Crossref
Crossref
Colleen M. Dovenport. (2003) A Primer on Bioterrorism: Potential Pathogens, Roles of United States Governmental Agencies, and Regulatory Models for Product Development. Drug Information Journal 37:3, pages 341-352.
Crossref
Crossref
Antero Airaksinen, Nonia Pariente, Luis Menéndez-Arias & Esteban Domingo. (2003) Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology 311:2, pages 339-349.
Crossref
Crossref
Carmen M Ruiz-Jarabo, Calvin Ly, Esteban Domingo & Juan Carlos de la Torre. (2003) Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308:1, pages 37-47.
Crossref
Crossref
S.M.L Waugh, D Pillay, D Carrington & W.F Carman. (2002) Antiviral prophylaxis and treatment (excluding HIV therapy). Journal of Clinical Virology 25:3, pages 241-266.
Crossref
Crossref
J RHODES. (2002) Discovery of immunopotentiatory drugs: current and future strategies. Clinical and Experimental Immunology 130:3, pages 363-369.
Crossref
Crossref
Emily L. Sherwin. (2004) Unjust Enrichment in Heartbreak Cases. SSRN Electronic Journal.
Crossref
Crossref